NOIDS.wiki
Calculator
Shop Potency Calculator
Cannabis Science

Delta-8-THC: Specs, Evidence, and Safety Status

Cannabinoid index · Intoxicating

Intoxicating (milder)FDA safety warningsNot approvedWADA-prohibited

Delta-8-THC is itself a form of THC: an isomer of delta-9-THC that is intoxicating but generally milder, occurs naturally only in trace amounts and is mostly made by converting CBD. The FDA has issued consumer warnings about delta-8 products over safety and mislabelling; it is not an approved medicine.

Specification
Compound
Delta-8-THC (Delta-8-tetrahydrocannabinol)
Relationship
Isomer of delta-9-THC (double bond in a different position)
Classification
Phytocannabinoid; mostly semi-synthetic in commerce
CAS number
5957-75-5
Molecular formula
C21H30O2
Molecular weight
314.46 g/mol
Intoxicating
Yes, but generally milder than delta-9-THC
Solubility
Fat-soluble; poorly water-soluble

How it is made, and infusion

Natural amount
Trace only; not a significant part of raw flower
Commercial source
Usually converted from CBD in a lab, which can leave reaction by-products
Purity concern
Because it is synthesised, unregulated products vary and may contain impurities
Infusion
Fat-soluble like other THC forms, but its trace natural level makes home extraction impractical

Unlike THC or CBD, delta-8 is not something you meaningfully decarb from flower; it is a manufacturing product.

Evidence & status
Approval status
Not approved. The FDA has issued consumer warnings about delta-8-THC products, citing adverse-event reports and inconsistent, sometimes contaminated products.
Legal context
Contested. Marketed in some markets through a hemp-derived loophole; regulatory status varies widely and changes.
Strongest support
Limited older pharmacology; little modern clinical data
Competitive sport
Prohibited in-competition by WADA (cannabinoids, CBD excepted).
Lab workAnimal studiesHuman studiesApproved label

Reviewed 2026-09-04. Regulatory status varies by market and is not legal or medical advice.

What the published literature examined

Delta-8-THC’s basic pharmacology, as a CB1-active isomer of delta-9-THC with weaker intoxicating potency, comes from older studies. Most recent attention is not clinical but regulatory: the FDA and poison-control networks have documented adverse events tied to unregulated delta-8 products, and analyses have found that commercial products often do not match their labels and can carry synthesis by-products.

What is established, and what is not

Established: that delta-8-THC is intoxicating, an isomer of delta-9, and that most commercial delta-8 is synthesised from CBD, with real product-quality and safety concerns flagged by regulators. Not established: any approved therapeutic use, and the safety of unregulated products, which vary batch to batch. This page describes the compound and summarises status; it is not medical or legal advice.

Sources

  • US FDA. 5 Things to Know about Delta-8 Tetrahydrocannabinol (consumer update). fda.gov
  • US CDC. Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events. cdc.gov
  • Registered human studies for delta-8-THC. ClinicalTrials.gov
  • World Anti-Doping Agency. Prohibited List (cannabinoids, CBD excepted). wada-ama.org

Frequently asked questions

Is delta-8 the same as regular THC?

No, but it is close: delta-8 is an isomer of delta-9-THC, with the double bond in a different position. It is intoxicating but usually milder.

Is delta-8 natural?

Only in trace amounts. Most delta-8 products are made by converting CBD in a lab, which is why product quality and purity vary.

Has the FDA warned about delta-8?

Yes. The FDA has issued consumer warnings citing adverse-event reports and inconsistent, sometimes contaminated products. It is not an approved medicine.

Analytical Forensics and Regulatory Toxicology

Comparative receptor pharmacology shows that delta-8-THC acts as a partial agonist at CB1 and CB2 receptors with roughly half to two-thirds the potency of delta-9-THC, while retaining greater thermodynamic stability against oxidative degradation into cannabinol (CBN) (PubMed PMID 34886311). However, independent mass-spectrometry surveys of commercial delta-8-THC distillates synthesized from CBD consistently identify unquantified reaction by-products including olivetol, delta-10-THC, 9-ethoxyhexahydrocannabinol, and residual heavy-metal catalysts (PubMed PMID 34889611), reinforcing consumer safety advisories from the U.S. Centers for Disease Control and Prevention (CDC) and the European Union Drugs Agency (EUDA).

Part of the cannabinoid index.

Educational information about a compound. Not medical or legal advice.

This article is for educational purposes only. Always follow local laws regarding cannabis preparation and use.

Scroll to Top